Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hai Cheng

Showing results (431-440 of 470) with videos related to

Pageof 47
Sort By:
Frontiers in Immunology|May 2, 2025
The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapyLingling Yin, Bin Lv, Jiao Ge, et al.
Science Advances|November 26, 2021
Collapse of the Liangzhu and other Neolithic cultures in the lower Yangtze region in response to climate changeHaiwei Zhang, Hai Cheng, Ashish Sinha, et al.
Haematologica|November 20, 2025
Decitabine plus all-<i>trans</i> retinoic acid versus decitabine monotherapy for myelodysplastic syndromes with excess blasts: a multicenter, randomized controlled trialXinping Zhou, Yanjuan Lin, Yan Gao, et al.
Leukemia|June 29, 2020
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infectionYing Wang, Yang Liu, Xu Tan, et al.
Cytotherapy|April 16, 2024
Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapyHai Cheng, Yingjun Sun, Xiaoxue Zhang, et al.
The Lancet. Haematology|August 6, 2019
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trialZhiling Yan, Jiang Cao, Hai Cheng, et al.
Cytotherapy|September 16, 2024
Comprehensive characterization of cytopenia after chimeric antigen receptor-T cell infusion in patients with relapsed or refractory multiple myelomaHai Cheng, Lingyan Shao, Dandan Wang, et al.
Nature|June 3, 2016
Early Neanderthal constructions deep in Bruniquel Cave in southwestern FranceJacques Jaubert, Sophie Verheyden, Dominique Genty, et al.
Cytotherapy|March 12, 2023
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myelomaSha Ma, Hujun Li, Dian Zhou, et al.
Science Bulletin|March 1, 2025
Millennial-scale climate variability of the Asian summer monsoon over the last 690,000 years: insights from cave recordsXiaowen Niu, Jian Wang, Le Kang, et al.
Pageof 47

Showing results (431-440 of 470) with videos related to

Sort By:
Pageof 47
Frontiers in Immunology|May 2, 2025
The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapyLingling Yin, Bin Lv, Jiao Ge, et al.
Science Advances|November 26, 2021
Collapse of the Liangzhu and other Neolithic cultures in the lower Yangtze region in response to climate changeHaiwei Zhang, Hai Cheng, Ashish Sinha, et al.
Haematologica|November 20, 2025
Decitabine plus all-<i>trans</i> retinoic acid versus decitabine monotherapy for myelodysplastic syndromes with excess blasts: a multicenter, randomized controlled trialXinping Zhou, Yanjuan Lin, Yan Gao, et al.
Leukemia|June 29, 2020
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infectionYing Wang, Yang Liu, Xu Tan, et al.
Cytotherapy|April 16, 2024
Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapyHai Cheng, Yingjun Sun, Xiaoxue Zhang, et al.
The Lancet. Haematology|August 6, 2019
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trialZhiling Yan, Jiang Cao, Hai Cheng, et al.
Cytotherapy|September 16, 2024
Comprehensive characterization of cytopenia after chimeric antigen receptor-T cell infusion in patients with relapsed or refractory multiple myelomaHai Cheng, Lingyan Shao, Dandan Wang, et al.
Nature|June 3, 2016
Early Neanderthal constructions deep in Bruniquel Cave in southwestern FranceJacques Jaubert, Sophie Verheyden, Dominique Genty, et al.
Cytotherapy|March 12, 2023
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myelomaSha Ma, Hujun Li, Dian Zhou, et al.
Science Bulletin|March 1, 2025
Millennial-scale climate variability of the Asian summer monsoon over the last 690,000 years: insights from cave recordsXiaowen Niu, Jian Wang, Le Kang, et al.
Pageof 47